Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...

詳細記述

書誌詳細
第一著者: Heart Protection Study Collaborative Group
その他の著者: The Society for Vascular Surgery
フォーマット: Journal article
言語:English
出版事項: Elsevier 2007
主題:

類似資料